Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides

Combs, D.W.; Rampulla, M.S.; Russell, R.K.; Rampulla, R.A.; Klaubert, D.H.; Ritchie, D.; Meeks, A.S.; Kirchner, T.

Drug Design and Delivery 6(4): 241-254

1990


ISSN/ISBN: 0884-2884
PMID: 2083028
Document Number: 350851
A synthetic program of rational drug design was undertaken to develop a series of quinazoline-3-oxides as pulmonary-selective inhibitors of ovalbumin-induced, leukotriene-mediated bronchoconstriction. The most active and selective compounds contained a methyl group at the 4-position, a medium sized branched alkyl group at the 2-position, and a small electron donating group on the phenyl ring. Significant enhancement in selectivity was observed in comparing the pulmonary versus cardiovascular effects of these new bronchodilators with the effects of theophylline.

Document emailed within 1 workday
Secure & encrypted payments